VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy

(MedPage Today) -- TAMPA, Fla. -- As lines of therapy increased for recurrent ovarian cancer, so did the risk of venous thromboembolism (VTE), a retrospective study showed. Almost 80% of VTEs occurred in patients who had received three or more...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news